1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,022 | 0,034 | 12:32 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.04. | XFRA 61N1: AUSSETZUNG/SUSPENSION | 126 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSTAGEZERO LIFE SCIENC.... ► Artikel lesen | |
| 05.04. | Stagezero Life Sciences Ltd (2): Stagezero Life's application to OSC for MCTO denied | 4 | Stockwatch | ||
| 05.04. | StageZero Life Sciences Ltd: StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order | 344 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen | |
| 03.04. | Stagezero Life Sciences Ltd (2): Stagezero delays 2023 results filing until May 31 | 1 | Stockwatch | ||
| 03.04. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results | 249 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 2, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen | |
| 29.11.23 | Stagezero Life Sciences Ltd (2): Stagezero Life warrants to expire Dec. 4 | 3 | Stockwatch | ||
| 15.11.23 | Stagezero Life Sciences GAAP EPS of -$0.01, revenue of $0.75M | 2 | Seeking Alpha | ||
| 15.11.23 | Stagezero Life Sciences Ltd (2): Stagezero Life Sciences loses $3-million in nine months | 1 | Stockwatch | ||
| 15.11.23 | StageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update | 298 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / November 15, 2023 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic... ► Artikel lesen | |
| 14.11.23 | StageZero Life Sciences and My One Medical Source collaborate | 1 | The Market Herald Canada | ||
| 14.11.23 | StageZero Life Sciences Ltd: StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA | 402 | ACCESSWIRE | Aristotle and AVRT to be offered to My One Medical Source's Customer BaseTORONTO, ON / ACCESSWIRE / November 14, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company")... ► Artikel lesen | |
| 07.11.23 | Stagezero Life Sciences Ltd (2): Stagezero to offer mental support for cancer patients | 1 | Stockwatch | ||
| 07.11.23 | StageZero Life Sciences Ltd: StageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer Offerings | 212 | ACCESSWIRE | Care Oncology Partners with WellnessScript to Offer Mental Health support to cancer patientsTORONTO, ON / ACCESSWIRE / November 7, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero"... ► Artikel lesen | |
| 20.10.23 | StageZero Life Sciences Ltd: StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer Offerings | 480 | ACCESSWIRE | CareOncology partners with The Source Functional Nutrition to offer nutritional guidance to cancer patients.TORONTO, ON / ACCESSWIRE / October 20, 2023 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF)... ► Artikel lesen | |
| 20.06.23 | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024 | 368 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 20, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving... ► Artikel lesen | |
| 08.06.23 | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting | 469 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 7, 2023) - StageZero Life Sciences, Ltd (TSX: SZLS) (OTCQB: SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of... ► Artikel lesen | |
| 05.06.23 | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call | 487 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it will host a conference call as part of its Special... ► Artikel lesen | |
| 16.05.23 | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd Announces Q1 2023 Financial Results - 15.2% Growth in Revenue over Q4 2022 - and Operational Update | 265 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 16, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company"), a vertically-integrated healthcare company devoted to improving the early detection... ► Artikel lesen | |
| 15.05.23 | StageZero Life Sciences Ltd.: StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023 | 336 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 15, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its first quarter 2023 operational results... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 101,40 | -1,17 % | Carl Zeiss Meditec: Risiken bei der Prognose | Am 8. Mai wird Carl Zeiss Meditec Zahlen zum zweiten Quartal publizieren. Die Analysten der Deutschen Bank rechnen beim Umsatz mit einem organischen Rückgang um 1 Prozent. Das EBIT soll um 27 Prozent... ► Artikel lesen | |
| INTUITIVE SURGICAL | 352,35 | +0,03 % | Opening Bell: Alcoa, Netflix, Intuitive Surgical, Nvidia, Micron Technology, Coupang | Die US-Indizes starteten gestern zunächst mit Zugewinnen in den Tag. Im Laufe des Handels drehten sie dann aber wieder ins Minus. Der Dow Jones gab schließlich 0,12 Prozent ab. Der Nasdaq 100 verlor... ► Artikel lesen | |
| PLUS THERAPEUTICS | 1,592 | +2,98 % | Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense | ||
| BOSTON SCIENTIFIC | 66,00 | +2,33 % | Boston Scientific Q1 2024 Earnings Preview | ||
| MOUNTAIN VALLEY MD | 0,033 | -19,81 % | Mountain Valley MD Holdings Inc: Mountain Valley MD grants options to buy 3 M shares | ||
| ASENSUS SURGICAL | 0,220 | -2,56 % | Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG | RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) ("Asensus" or the "Company"), a medical device company that is digitizing the interface... ► Artikel lesen | |
| INVIVO THERAPEUTICS HOLDINGS | 0,302 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
| MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve changes auditor to MS Partners | ||
| REWALK ROBOTICS | 4,675 | 0,00 % | ReWalk Robotics Ltd. - 8-K, Current Report | ||
| SENSEONICS | 0,386 | -3,95 % | Senseonics Holdings, Inc. Announces Data From the Eversense Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes | Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for... ► Artikel lesen | |
| EKSO BIONICS | 1,055 | -1,86 % | Ekso Bionics Holdings, Inc.: Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024 | ||
| BIOCEPT | 6,800 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.11.2023 | The following instruments on Boerse Frankfurt do have their last trading day on 02.11.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.11.2023ISIN NameCA91834N1006 VSBLTY... ► Artikel lesen | |
| IMUNON | 1,180 | -4,84 % | Imunon, Inc.: IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101 | Company expects enrollment in Phase 1 proof-of-concept study of DNA-based vaccine technology to begin in the second quarter LAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:... ► Artikel lesen | |
| AVINGER | 2,750 | -100,00 % | Avinger, Inc.: Avinger Reports Fourth Quarter and Full Year 2023 Results | New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens New Pathway for Sales in AsiaREDWOOD CITY, CA / ACCESSWIRE / March 20, 2024 / Avinger... ► Artikel lesen | |
| ROCKWELL MEDICAL | 1,446 | +1,47 % | Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023 | WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis... ► Artikel lesen |
Das Unternehmen STAGEZERO LIFE SCIENCES LTD kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,028 (-100,00 %) liegt der Kurs bei 0,028 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
